Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1α response in ulcerative colitis patients.

Brown E, Rowan C, Strowitzki MJ, Fagundes RR, Faber KN, Güntsch A, Halligan DN, Kugler J, Jones F, Lee CT, Doherty G, Taylor CT.

FASEB J. 2020 Jan 16. doi: 10.1096/fj.201902103R. [Epub ahead of print]

PMID:
31944416
2.

Prolyl Hydroxylase Inhibition Mitigates Pouchitis.

Harnoss JM, Gebhardt JM, Radhakrishnan P, Leowardi C, Burmeister J, Halligan DN, Yuan S, Kennel KB, Strowitzki MJ, Schaible A, Lasitschka F, Taylor CT, Schneider M.

Inflamm Bowel Dis. 2020 Jan 6;26(2):192-205. doi: 10.1093/ibd/izz218.

PMID:
31618435
3.

Mechanisms and Consequences of Oxygen and Carbon Dioxide Sensing in Mammals.

Cummins EP, Strowitzki MJ, Taylor CT.

Physiol Rev. 2020 Jan 1;100(1):463-488. doi: 10.1152/physrev.00003.2019. Epub 2019 Sep 20.

PMID:
31539306
4.

Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?

Strowitzki MJ, Ritter AS, Kimmer G, Schneider M.

Pharmacol Res. 2019 Sep;147:104364. doi: 10.1016/j.phrs.2019.104364. Epub 2019 Jul 31. Review.

PMID:
31376431
5.

Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?

Strowitzki MJ, Cummins EP, Taylor CT.

Cells. 2019 Apr 26;8(5). pii: E384. doi: 10.3390/cells8050384. Review.

6.

High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.

Strowitzki MJ, Radhakrishnan P, Pavicevic S, Scheer J, Kimmer G, Ritter AS, Tuffs C, Volz C, Vondran F, Harnoss JM, Klose J, Schmidt T, Schneider M.

Br J Cancer. 2019 Apr;120(7):675-688. doi: 10.1038/s41416-019-0406-9. Epub 2019 Feb 27.

PMID:
30808993
7.

Pharmacologic inhibition of hypoxia-inducible factor (HIF)-hydroxylases ameliorates allergic contact dermatitis.

Manresa MC, Smith L, Casals-Diaz L, Fagundes RR, Brown E, Radhakrishnan P, Murphy SJ, Crifo B, Strowitzki MJ, Halligan DN, van den Bogaard EH, Niehues H, Schneider M, Taylor CT, Steinhoff M.

Allergy. 2019 Apr;74(4):753-766. doi: 10.1111/all.13655. Epub 2018 Dec 12.

PMID:
30394557
8.

Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells.

Strowitzki MJ, Kirchberg J, Tuffs C, Schiedeck M, Ritter AS, Biller M, Harnoss JM, Lasitschka F, Schmidt T, Radhakrishnan P, Ulrich A, Schneider M.

Am J Pathol. 2018 Dec;188(12):2826-2838. doi: 10.1016/j.ajpath.2018.08.003. Epub 2018 Sep 22.

9.

Prognostic indicators lose their value with repeated resection of colorectal liver metastases.

Schmidt T, Nienhüser H, Kuna C, Klose J, Strowitzki MJ, Büchler MW, Ulrich A, Schneider M.

Eur J Surg Oncol. 2018 Oct;44(10):1610-1618. doi: 10.1016/j.ejso.2018.07.051. Epub 2018 Jul 31.

PMID:
30115500
10.

Pharmacological HIF-inhibition attenuates postoperative adhesion formation.

Strowitzki MJ, Ritter AS, Radhakrishnan P, Harnoss JM, Opitz VM, Biller M, Wehrmann J, Keppler U, Scheer J, Wallwiener M, Schmidt T, Ulrich A, Schneider M.

Sci Rep. 2017 Oct 13;7(1):13151. doi: 10.1038/s41598-017-13638-z.

11.

Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.

Sisic L, Strowitzki MJ, Blank S, Nienhueser H, Dorr S, Haag GM, Jäger D, Ott K, Büchler MW, Ulrich A, Schmidt T.

Gastric Cancer. 2018 May;21(3):552-568. doi: 10.1007/s10120-017-0751-4. Epub 2017 Jul 24.

PMID:
28741059
12.

Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, Nienhueser H, Haag GM, Bruckner T, Mihaljevic AL, Ott K, Büchler MW, Ulrich A.

Gastric Cancer. 2018 Mar;21(2):303-314. doi: 10.1007/s10120-017-0746-1. Epub 2017 Jul 6.

PMID:
28685209
13.

Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis.

Strowitzki MJ, Schmidt T, Keppler U, Ritter AS, Mahmoud S, Klose J, Mihaljevic AL, Schneider M, Büchler MW, Ulrich AB.

J Surg Oncol. 2017 Aug;116(2):149-158. doi: 10.1002/jso.24631. Epub 2017 Apr 13.

PMID:
28409832
14.

Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth.

Harnoss JM, Platzer LK, Burhenne J, Radhakrishnan P, Cai J, Strowitzki MJ, Weiss J, Ritter AS, Mollenhauer M, Schmidt T, Ulrich A, Haefeli WE, Schneider M.

Ann Surg. 2017 Apr;265(4):782-791. doi: 10.1097/SLA.0000000000001696.

PMID:
28266966
15.

Neither Isolated Hepatic Arterial Clamping nor Hepatic Arterial Ligation Induce Ischemic Type Biliary Lesions in Rats.

Keppler U, Moussavian MR, Jeanmonod P, Strowitzki MJ, Wagner M, Scheuer C, Menger MD, von Heesen M.

Ann Transplant. 2016 Oct 21;21:649-659.

16.

Preconditioning by cilostazol protects against cold hepatic ischemia-reperfusion injury.

von Heesen M, Müller S, Keppler U, Strowitzki MJ, Scheuer C, Schilling MK, Menger MD, Moussavian MR.

Ann Transplant. 2015 Mar 26;20:160-8. doi: 10.12659/AOT.893031.

17.

Isoflurane does not protect from brain death-associated aggravation of cold hepatic ischemia-reperfusion injury.

Strowitzki MJ, Moussavian MR, Keppler U, Schilling MK, Menger MD, von Heesen M.

Ann Transplant. 2015 Jan 19;20:36-43. doi: 10.12659/AOT.892302.

18.

Influence of age on resection of colorectal liver metastases.

Schmidt T, Strowitzki MJ, Reissfelder C, Rahbari NN, Nienhueser H, Bruckner T, Rahäuser C, Keppler U, Schneider M, Büchler MW, Ulrich A.

J Surg Oncol. 2015 May;111(6):729-39. doi: 10.1002/jso.23872. Epub 2015 Jan 16.

PMID:
25597497
19.

The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.

Strowitzki MJ, Dold S, von Heesen M, Körbel C, Scheuer C, Moussavian MR, Schilling MK, Kollmar O, Menger MD.

Clin Exp Metastasis. 2014 Oct;31(7):795-803. doi: 10.1007/s10585-014-9669-y. Epub 2014 Jul 23.

PMID:
25051901

Supplemental Content

Loading ...
Support Center